| Literature DB >> 33790685 |
Sunil Jain1, Abhijith Santhosh2.
Abstract
PURPOSE: Current recommendations for 'Febrile seizures' management include emergency first aid and treatment along with intermittent prophylaxis. Evidence of practices, efficacy, side-effects, and complications should lead to refined and rational management strategies. PATIENTS AND METHODS: Study of cases referred and treated at a tertiary level hospital, providing referral services to a large state in India. Evidence sought for the research questions identified, these were (i) immediate treatment: First aid components and practices; response to drug treatment (ii) intermittent prophylaxis: effectiveness, compliance, and side-effects (iii) complications arising due to treatment side-effects: quantifying the number of cases of CNS infections missed as a result of alterations in consciousness levels due to benzodiazepines.Entities:
Keywords: benzodiazepines; emergency treatment; first aid; meningitis; monitoring; prophylaxis
Year: 2021 PMID: 33790685 PMCID: PMC8007563 DOI: 10.2147/PHMT.S294729
Source DB: PubMed Journal: Pediatric Health Med Ther ISSN: 1179-9927
Aims of the Study
| Worldwide Trend | Current Evidence | Our Study Aims |
|---|---|---|
| Immediate treatment: | ► First aid- | Assess practices of our clientele so as to guide future interventions |
| ►Most children with PFS | What is the response rate in our setting. | |
| Intermittent prophylaxis: | Cochrane review has reported reduced recurrence rates for children with febrile seizures for intermittent diazepam, with adverse effects recorded in up to 36% of children. | Defining & delineating the solution and problem |
| Complications: | In infants 6 to 12 months of age with febrile seizures, lumbar puncture (LP) is an option if they have not received recommended Haemophilus influenzae type b (Hib) or pneumococcal vaccinations, or if their immunization status is unknown. Evidence level: reasoning from clinical experience, case series. | Quantifying the number of cases of CNS infections missed due to alterations in consciousness levels because of benzodiazepines, even when Pneumococcal vaccination is not part of routine schedule. |
Clinical Characteristics
| Characteristics | Diagnosis | Overall | |||||
|---|---|---|---|---|---|---|---|
| Simple Febrile Seizures | Complex Febrile Seizures | Febrile Status Epilepticus | |||||
| Age | Range | 06–38 months | 06–60 months | 07–21 months | 06–60 months | ||
| Mean | 10 months | 19 months | 14 months | 12.5 months | |||
| Sex | Males | 34 | 11 | 2 | 47 | ||
| Females | 26 | 10 | 2 | 38 | |||
| M: F ratio | 1.31:1 | 1.1:1 | 1:1 | 1.24:1 | |||
| Mothers education | Less than Secondary school | 16 (22.67) | 01 (04.55) | 0 | 18 (21.18) | ||
| Secondary school | 22 (36.67) | 15 (71.43) | 01 (25) | 38 (44.71) | |||
| Senior Secondary | 08 (13.33) | 02 (09.52) | 01 (25) | 11 (12.94) | |||
| Under Graduate | 05 (08.33) | 02 (09.52) | 01 (25) | 08 (9.41) | |||
| Post Graduate | 07 (11.67) | 01 (04.76) | 01 (25) | 09 (10.59) | |||
| Doctorate | 02 (03.33) | 0 | 0 | 02 (2.35) | |||
| Time for reaching nearest medical facility/Command Hospital (Northern Command) (in minutes) | 10–45 | 15–25 | 10–45 | 10–45 | |||
| Distance from home to nearest medical facility/Command Hospital (Northern Command) | 02–35 km | 04–15 km | 02–35 km | 02–35 km | |||
| Immunization status | Haemophilus influenzae type b (Hib) | Complete for age | 58 (96.67) | 19 (90.48) | 03 (75) | 80 (94.12) | |
| Incomplete for age | 02 (03.33) | 02 (09.52) | 01 (25) | 05 (05.88) | |||
| Pneumococcal | Complete for age | 45 (75.00) | 13 (61.90) | 02 (50) | 60 (70.59) | ||
| Incomplete for age | 15 (25.00) | 08 (38.10) | 02 (50) | 25 (29.41) | |||
Note: Figures in parenthesis () are percentage.
Research Question Findings: Complication – CNS Infection
| Clinical Characteristics and Investigation | Number of Cases | ||
|---|---|---|---|
| Children presenting with seizures and fever | CSF examination done | CNS infection diagnosed | 13 (76.47) |
| CNS infection not present | 04 (23.53) | ||
| CSF examination not done | CNS infection diagnosed | 0 | |
| CNS infection not present | 81 (100) | ||
| Febrile seizure cases with benzodiazepines administered | CSF examination done | CNS infection diagnosed | 01 (25) |
| CNS infection not present | 03 (75) | ||
| CSF examination not done | CNS infection diagnosed | 0 | |
| CNS infection not present | 56 (100) | ||
| Masking an evolving CNS infection due to alterations in consciousness levels caused by any of the benzodiazepines | Complete immunization status | NIL | |
| Incomplete immunization status | NIL | ||
Note: Figures in parenthesis () are percentage.
Research Question Findings: Immediate Treatment
| Clinical Characteristics | Number | |||
|---|---|---|---|---|
| Technically correct first aid | Scoring criteria | Score | ||
| 01 point for each component | 0 | 03 (03.53) | ||
| - Stayed calm | 01 | 13 (15.30) | ||
| - Protection of the child from injury | 02 | 34 (40.00) | ||
| - Turned the child onto his or her side | 03 | 22 (25.88) | ||
| - Did not put anything in the child’s mouth | 04 | 13 (15.30) | ||
| Response to emergency treatment | Initial treatment used Seizure lasting 5–15 minutes | Rectal diazepam | Controlled | 08 (57.14) |
| Not controlled | 06 (42.86) | |||
| Intranasal midazolam n = 21 (60) | Controlled | 15 (71.43) | ||
| Not controlled | 06 (28.57) | |||
| IV lorazepam | Controlled | 01 (08.33) | ||
| Not controlled | 11 (91.66) | |||
| Treatment used Un-controlled/PFS (>15 min) | IV phenobarbitone | Controlled | 07 (63.64) | |
| Not controlled | 04 (36.36) | |||
| Treatment used Un-controlled/FSE | IV fosphenytoin | Controlled | 01 (25.00) | |
| IV valproate | Controlled | 02 (50.00) | ||
| IV levetiracetam | Controlled | 01 (25.00) | ||
Note: Figures in parenthesis () are percentage.
Research Question Findings: Intermittent Prophylaxis n=25
| Clinical Characteristics | Number | |
|---|---|---|
| Reason for prescribing | Frequent recurrence ≥ 2 in six months | 07 (28) |
| Prolonged seizure ≥ 5 minutes | 10 (40) | |
| Living remote from medical help | 08 (32) | |
| Clientele’s (parents) adherence | Prophylaxis compliance | 20 (80) |
| Effects | No seizure | 18 (90) |
| Seizure occurrence | 02 (10) | |
| Side-effects | Lethargy | 05 (22.73) |
| Drowsiness | 02 (9.09) | |
| Ataxia | 01 (4.55) | |
| Respiratory depression | NIL | |
| Total | 08 (36.33) | |
| Non adherence reasons | Poor compliance | 02 (40) |
| Side-effects | 03 (60) Drowsiness | |
Note: Figures in parenthesis () are percentage.